Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interrad's SecurAcath cleared by FDA

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Interrad Medical's SecurAcath Universal, a system to secure central venous catheters. It uses a small, blunt anchor that is deployed just beneath the skin. Traditionally, catheters are secured using sutures or adhesive devices, but they can become dislodged and some patients are allergic to the adhesives. SecurAcath can reduce costs by decreasing the time needed for procedures, and permits fewer catheter-related infections because it reduces catheter movement and allows improved cleaning of the catheter site, Plymouth, Minnesota-based Interrad claims. SecurAcath Universal is also approved in Europe and Canada. An earlier product, SecurAcath PICC, was cleared by the FDA in October 2008.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel